Catalyst Wire Dossier Catalyst Wire Dossier

BRYNOVIN

Sitagliptin hydrochloride · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRYNOVIN, covering 2025-01-16 to 2025-01-16. Get the full timeline:

Most recent: FDA Approved: BRYNOVIN — Original Application (Azurity Pharmaceuticals, Inc.)

See pricing